Wockhardt Bio Stock Forecast for 2023 - 2025 - 2030

Updated on 03/28/2024

Stock Rating
0
Price Target
1.07
Consensus
-
Upside
4.90%
Analysts
0
Stock Rating
0
Upside
4.90%
Analysts
0
Price Target
1.07

Wockhardt Bio Stock Forecast and Price Target

The average price target of 1.07 for Wockhardt Bio's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 4.9% from the last closing price in November, 2021 if reached by the end of the year. This potential increase is based on a high estimate of 1.20 and a low estimate of 0.96. If you are not interested in WBIO stock, you may still be interested in its competitors and their current standings.

1.07

4.90% Upside

-

Wockhardt Bio Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Wockhardt Bio's Price has grown, moving from 0.00 to 0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to 1.02 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.

2024 Fair Value Forecast
1.02
2025 Fair Value Forecast
1.12
2026 Fair Value Forecast
1.22
2027 Fair Value Forecast
1.33
2028 Fair Value Forecast
1.46
2029 Fair Value Forecast
1.60
2030 Fair Value Forecast
1.75
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NESN Stock Forecast Nestlé Outperform 11
CHF93.99 Buy/Sell CHF115.58 16.50%
ROG Stock Forecast Roche Holding Hold 16
CHF242.00 Buy/Sell CHF307.83 11.57%
NOVN Stock Forecast Novartis Outperform 10
CHF88.80 Buy/Sell CHF105.00 23.95%
CFR Stock Forecast Compagnie Financière Richemon... Outperform 17
CHF144.95 Buy/Sell CHF147.55 4.45%
ABBN Stock Forecast ABB Ltd Hold 11
CHF40.95 Buy/Sell CHF42.44 5.05%

Wockhardt Bio Revenue Forecast for 2023 - 2025 - 2030

In the last year, Wockhardt Bio's Revenue has seen a drop from 315.14M to 264.94M – a 15.93% decrease. In the next year, analysts predict that Revenue will jump to 315.15M – up 18.95% from the current level. Looking ahead to nine years, experts forecast that Revenue will grow by 13.73%.

2022 Rev Forecast
0.32B
2023 Rev Forecast
0.30B
2024 Rev Forecast
0.31B
2025 Rev Forecast
0.29B
2026 Rev Forecast
0.30B
2027 Rev Forecast
0.30B
2028 Rev Forecast
0.30B
2029 Rev Forecast
0.30B
2030 Rev Forecast
0.30B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GLEN Stock Forecast Glencore Outperform 2
£3.98 Buy/Sell £6.66 52.26%
HOLN Stock Forecast Holcim Ltd Outperform 12
CHF75.28 Buy/Sell CHF64.56 -0.37%
TEL Stock Forecast TE Connectivity Outperform 10
$141.03 Buy/Sell $158.67 12.03%

Wockhardt Bio Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GIVN Stock Forecast Givaudan Hold 14
CHF3.94k Buy/Sell CHF3.14k -16.22%
LONN Stock Forecast Lonza Group Buy 16
CHF458.20 Buy/Sell CHF516.89 12.61%
PGHN Stock Forecast Partners Group Holding Outperform 10
CHF1.27k Buy/Sell CHF1.07k -5.81%

Wockhardt Bio Free Cash Flow Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
KNIN Stock Forecast Kuehne + Nagel International Underperform 8
CHF245.40 Buy/Sell CHF246.86 -3.83%
DSFIR Stock Forecast DSM-Firmenich Outperform 18
104.30€ Buy/Sell 114.60€ 15.05%
SCMN Stock Forecast Swisscom Hold 14
CHF508.80 Buy/Sell CHF558.69 13.01%

Wockhardt Bio EBITDA Forecast for 2023 - 2025 - 2030

In the last year, Wockhardt Bio's EBITDA has decreased from 35.04M to 22.84M – a 34.82% drop. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach 35.04M – an increase of 53.42%. Over the next nine years, experts anticipate that EBITDA growth for Wockhardt Bio will be 44.57%.

2022 EBITDA Forecast
0.04B
2023 EBITDA Forecast
0.03B
2024 EBITDA Forecast
0.04B
2025 EBITDA Forecast
0.03B
2026 EBITDA Forecast
0.03B
2027 EBITDA Forecast
0.03B
2028 EBITDA Forecast
0.03B
2029 EBITDA Forecast
0.03B
2030 EBITDA Forecast
0.03B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LISN Stock Forecast Hold 3
CHF109.40k Buy/Sell CHF103.73k 0.55%
SCHN Stock Forecast Schindler Holding Outperform 16
CHF223.80 Buy/Sell CHF209.44 2.77%
GEBN Stock Forecast Geberit Underperform 18
CHF526.60 Buy/Sell CHF439.17 -16.45%

Wockhardt Bio EBIT Forecast for 2023 - 2025 - 2030

In the last year, Wockhardt Bio's EBIT has decreased by 54.07%, going from 26.30M to 12.08M. In the next year, analysts predict that EBIT will reach 26.30M – an increase of 117.72%. For the next nine years, the forecast is for EBIT to grow by 121.90%.

2022 EBIT Forecast
0.03B
2023 EBIT Forecast
0.03B
2024 EBIT Forecast
0.03B
2025 EBIT Forecast
0.02B
2026 EBIT Forecast
0.03B
2027 EBIT Forecast
0.03B
2028 EBIT Forecast
0.03B
2029 EBIT Forecast
0.03B
2030 EBIT Forecast
0.03B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
SGSN Stock Forecast SGS Hold 18
CHF87.16 Buy/Sell CHF86.34 0.39%
EMSN Stock Forecast EMS-CHEMIE HOLDING Hold 18
CHF619.00 Buy/Sell CHF657.14 2.91%
AMCR Stock Forecast Amcor Hold 13
$9.47 Buy/Sell $9.67 5.07%

Wockhardt Bio EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Wockhardt Bio's EPS has grown, moving from 0.00 to 0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to 0.00 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.

2024 EPS Forecast
0.00
2025 EPS Forecast
0.00
2026 EPS Forecast
0.00
2027 EPS Forecast
0.00
2028 EPS Forecast
0.00
2029 EPS Forecast
0.00
2030 EPS Forecast
0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LOGN Stock Forecast Logitech International Hold 18
CHF79.30 Buy/Sell CHF73.92 4.56%
CSGN Stock Forecast Credit Suisse Group - 11
CHF0.75 Buy/Sell CHF1.51 -100.00%
BAER Stock Forecast Julius Bär Gruppe Outperform 14
CHF50.46 Buy/Sell CHF64.09 12.96%